24 mg, tablets
Betahistine dihydrochloride
Betaserc contains betahistine. Betaserc is a type of medicine called a "histamine analogue".
Betaserc is used to treat Meniere's disease, which is characterized by the following symptoms:
In the symptomatic treatment of vertigo of vestibular origin.
Betaserc works by improving blood flow in the inner ear. This reduces increased pressure.
Before taking Betaserc, the patient should consult a doctor or pharmacist if:
Betaserc is not recommended for use in children under 18 years of age.
The patient should tell the doctor or pharmacist about all medicines they are currently taking or have recently taken, including those obtained without a prescription and herbal medicines.
In particular, the patient should inform the doctor or pharmacist if they are taking any of the following medicines:
Betaserc can be taken with or without food. However, Betaserc may cause mild stomach upset (listed in section 4). Taking Betaserc with food may help reduce stomach upset.
It is not known whether Betaserc affects the fetus:
It is not known whether Betaserc passes into breast milk:
It is unlikely that Betaserc will affect the ability to drive or use machines.
However, the patient should remember that the diseases being treated with betahistine (Meniere's disease and vertigo) can cause dizziness and nausea and may affect the ability to drive or use machines.
Betaserc should always be taken as directed by the doctor. In case of doubts, the patient should consult a doctor or pharmacist.
Betaserc is available in two strengths: 8 mg and 24 mg. The usual dose is:
If more than one tablet is taken per day, the patient should space out the doses evenly throughout the day, e.g., take one tablet in the morning and one in the evening. The patient should try to take the tablets at the same time every day. This will help keep a steady amount of medicine in the body.
Taking the medicine at the same time every day will also help the patient remember to take it.
If more Betaserc is taken than prescribed, the patient may experience nausea, drowsiness, or stomach pain. In case of doubts, the patient should consult a doctor.
The patient should not stop taking Betaserc without consulting a doctor, even if they feel better.
In case of any further doubts about the use of the medicine, the patient should consult a doctor or pharmacist.
Like all medicines, Betaserc can cause side effects, although not everybody gets them.
After taking this medicine, the following side effects may occur:
If an allergic reaction occurs, the patient should stop taking Betaserc and consult a doctor or go to the nearest hospital immediately. The symptoms may be:
Common(occurring in less than 1 in 10 people):
Taking Betaserc with food may help reduce stomach upset.
If any side effects occur, including any possible side effects not listed in the leaflet, the patient should inform the doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 22 49 21 301; fax: +48 22 49 21 309; website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be gathered on the safety of the medicine.
Betaserc 24 mg betahistine dihydrochloride is available in the form of round, biconvex, divisible, white to almost white tablets with a score line. They have a diameter of 10 mm and are engraved with "289" on one side of the tablet on either side of the score line. The score line on the tablet is only to facilitate breaking and not to divide into equal doses.
Betaserc, 24 mg is available in packs of 20, 60, or 100 tablets, packaged in PVC-PVDC/Al blisters in a cardboard box.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15, Dublin, Ireland
Mylan Laboratories S.A.S.
Route de Belleville
Lieu-dit Maillard
01400 Châtillon-sur-Chalaronne
France
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Marketing authorization number in Romania, the country of export: 2717/2010/03
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.